NCT01736527View on ClinicalTrials.gov

Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2013

Study Completion Date

April 30, 2013

Conditions
Pharmacokinetics
Interventions
DRUG

LE Gel

Single drop of LE Gel 0.5% administered to the study eye on visit 2

Trial Locations (1)

14609

Bausch & Lomb Research Clinic, Rochester

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT01736527 - Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation | Biotech Hunter | Biotech Hunter